Do you want to read an article? Please log in or register.
Impact of hyponatremia on mortality and morbidity in patients with COPD exacerbations
Related content
RECOMMENDED
COPD
Susceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med.
Ouaalaya EH, Falque L, Dupis JM, Sabatini M, Bernady A, Nguyen L, Ozier A, Nocent-Ejnaini C, Le Guillou F, Molimard M, Zysman M, Raherison-Semjen C
doi: 10.1016/j.rmed.2020.106018.
COPD
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
Respir Res.
Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD; Canadian Respiratory Research Network (CRRN)
doi: 10.1186/s12931-018-0733-z.
RECOMMENDED
COPD
Impact of mild-to-moderate exacerbations on outcomes of neuromuscular electrical stimulation (NMES) in patients with COPD
★ 1
Recommended by
Dr Martin Frey, Faculty Member
Respir Med.
Meys R, Sillen MJ, Franssen FME, Stoffels AAF, Wouters EFM, van Hees HWH, van den Borst B, Klijn PH, Spruit MA, BASES-consortium.
doi: 10.1016/j.rmed.2019.105851.
RECOMMENDED
COPD
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in COPD Patients
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Lipson DA, Crim C, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Lettis S, Manchester P, Martin N, Midwinter D, Morris A, Pascoe SJ, Singh D, Wise RA, Martinez FJ, IMPACT investigators.
doi: 10.1164/rccm.201911-2207OC.
RECOMMENDED
COPD
Airway fractal dimension predicts respiratory morbidity and mortality in COPD
J Clin Invest.
Bodduluri S, Puliyakote ASK, Gerard SE, Reinhardt JM, Hoffman EA, Newell JD Jr, Nath HP, Han MK, Washko GR, San José Estépar R, Dransfield MT, Bhatt SP, Investigators C
doi: 10.1172/JCI120693.
RECOMMENDED
COPD
Efficacy of FF/UMEC/VI compared with FF/VI and UMEC/VI in patients with COPD: subgroup analysis of the Spain cohort in IMPACT
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Marín JM, Mateos L, Roldán J, Echave-Sustaeta JM, Pascual-Guardia S, Pardo MV, Velasco B, Jones CE, Kilbride S, Lipson DA
doi: 10.1177/1753466620963021
COPD
Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial.
Int J Chron Obstruct Pulmon Dis.
Beeh KM, Beier J, Candler H, Wittig T
doi: 10.2147/COPD.S11765
AsthmaCOPD
Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Eur Respir J.
Whittaker HR, Bloom C, Morgan A, Jarvis D, Kiddle SJ, Quint JK
doi: 10.1183/13993003.
AsthmaCOPD
Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey
Int J Chron Obstruct Pulmon Dis
Ding B, Small M
doi: 10.2147/COPD.S136314.